Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ALLSTATE CORPALL · Entity 2989 | Pres, Invest. & Corp. Strategy | October 03, 2026 | October 06, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ALLSTATE CORP
Report date October 03, 2026 · Filed October 06, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 13,934 |
Ending reported balance
After 2026-10-03 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-10-03 · Exercise / conversion · Acquired 1,581 · Balance 14,635 F1: Conversion of previously awarded Restricted Stock Units (RSUs) into an equal number of common shares, without the payment of any consideration, pursuant to The Allstate Corporation 2019 Equity Incentive Plan. The remaining RSUs will convert on October 3, 2027 and October 3, 2028. Row 2 · 2026-10-03 · Tax withholding · Disposed 701 · Balance 13,934 |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Expires 2028-10-03 | Direct | 3,162 |
Reported balance
After 2026-10-03 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-10-03 · Exercise / conversion · Disposed 1,581 · Balance 3,162 F1: Conversion of previously awarded Restricted Stock Units (RSUs) into an equal number of common shares, without the payment of any consideration, pursuant to The Allstate Corporation 2019 Equity Incentive Plan. The remaining RSUs will convert on October 3, 2027 and October 3, 2028. |
| Common StockSEC Table I · non-derivative | IndirectBy 401(k) Plan | 343 |
Reported balance
Holding disclosure · report date 2026-10-03 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 343 |
Filing footnotes · ownership attribution and instrument terms
F1: Conversion of previously awarded Restricted Stock Units (RSUs) into an equal number of common shares, without the payment of any consideration, pursuant to The Allstate Corporation 2019 Equity Incentive Plan. The remaining RSUs will convert on October 3, 2027 and October 3, 2028.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 03, 2026 Filed Oct 6, 2026 20:25 UTC | ALLSTATE CORP ALL · Entity 2989 | Exercise / conversionRestricted Stock Units · Derivative | 1,581 | $0.00 | $0.00 |
DisclosureSEC source: 0000899051-26-000148 · form4.xml · derivative · entry 4 Dugenske John E · CIK 0001699842 · Pres, Invest. & Corp. Strategy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,162 Underlying: Common Stock · 1,581 shares Expires 2028-10-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Conversion of previously awarded Restricted Stock Units (RSUs) into an equal number of common shares, without the payment of any consideration, pursuant to The Allstate Corporation 2019 Equity Incentive Plan. The remaining RSUs will convert on October 3, 2027 and October 3, 2028. F1 · derivative.exercise_date: Conversion of previously awarded Restricted Stock Units (RSUs) into an equal number of common shares, without the payment of any consideration, pursuant to The Allstate Corporation 2019 Equity Incentive Plan. The remaining RSUs will convert on October 3, 2027 and October 3, 2028. Read SEC document |
| October 03, 2026 Filed Oct 6, 2026 20:25 UTC | ALLSTATE CORP ALL · Entity 2989 | Tax withholdingCommon Stock | 701 | $223.74 | $156,841.74 |
DisclosureSEC source: 0000899051-26-000148 · form4.xml · nonDerivative · entry 2 Dugenske John E · CIK 0001699842 · Pres, Invest. & Corp. Strategy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,934 Read SEC document |
| October 03, 2026 Filed Oct 6, 2026 20:25 UTC | ALLSTATE CORP ALL · Entity 2989 | Exercise / conversionCommon Stock | 1,581 | $0.00 | $0.00 |
DisclosureSEC source: 0000899051-26-000148 · form4.xml · nonDerivative · entry 1 Dugenske John E · CIK 0001699842 · Pres, Invest. & Corp. Strategy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,635 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Conversion of previously awarded Restricted Stock Units (RSUs) into an equal number of common shares, without the payment of any consideration, pursuant to The Allstate Corporation 2019 Equity Incentive Plan. The remaining RSUs will convert on October 3, 2027 and October 3, 2028. Read SEC document |
| August 07, 2026 Filed Aug 11, 2026 20:10 UTC | ALLSTATE CORP ALL · Entity 2989 | SaleCommon Stock | 25,717 | $268.80 | $6,912,806.75 |
DisclosureSEC source: 0000899051-26-000120 · form4.xml · nonDerivative · entry 3 Dugenske John E · CIK 0001699842 · Pres, Invest. & Corp. Strategy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,054 F3 · price: Reflects weighted average sale price for open-market sales transaction reported herein. Actual sale prices ranged from $268.370 to $269.165. The reporting person provided the issuer, and will provide any security holder of The Allstate Corporation or member of the SEC staff, full information regarding the number of shares sold at each separate price upon request. Read SEC document |
| August 07, 2026 Filed Aug 11, 2026 20:10 UTC | ALLSTATE CORP ALL · Entity 2989 | SaleCommon Stock | 3,901 | $272.05 | $1,061,267.05 |
DisclosureSEC source: 0000899051-26-000120 · form4.xml · nonDerivative · entry 2 Dugenske John E · CIK 0001699842 · Pres, Invest. & Corp. Strategy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,771 F2 · price: Reflects weighted average sale price for open-market sales transaction reported herein. Actual sale prices ranged from $271.570 to $272.090. The reporting person provided the issuer, and will provide any security holder of The Allstate Corporation or member of the SEC staff, full information regarding the number of shares sold at each separate price upon request. Read SEC document |
| August 07, 2026 Filed Aug 11, 2026 20:10 UTC | ALLSTATE CORP ALL · Entity 2989 | SaleCommon Stock | 3,378 | $270.20 | $912,728.84 |
DisclosureSEC source: 0000899051-26-000120 · form4.xml · nonDerivative · entry 1 Dugenske John E · CIK 0001699842 · Pres, Invest. & Corp. Strategy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,672 F1 · price: Reflects weighted average sale price for open-market sales transaction reported herein. Actual sale prices ranged from $270.050 to $270.460. The reporting person provided the issuer, and will provide any security holder of The Allstate Corporation or member of the SEC staff, full information regarding the number of shares sold at each separate price upon request. Read SEC document |
| February 24, 2026 Filed Feb 26, 2026 21:09 UTC | ALLSTATE CORP ALL · Entity 2989 | Exercise / conversionRestricted Stock Units · Derivative | 1,033 | $0.00 | $0.00 |
DisclosureSEC source: 0000899051-26-000045 · form4.xml · derivative · entry 4 Dugenske John E · CIK 0001699842 · Chief Financial Officer · Pres, Invest. & Corp. Strategy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,066 Underlying: Common Stock · 1,033 shares Expires 2028-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Conversion of previously awarded Restricted Stock Units (RSUs) into an equal number of common shares, without the payment of any consideration, pursuant to The Allstate Corporation 2019 Equity Incentive Plan. The remaining RSUs will convert on February 24, 2027 and February 24, 2028 F1 · derivative.exercise_date: Conversion of previously awarded Restricted Stock Units (RSUs) into an equal number of common shares, without the payment of any consideration, pursuant to The Allstate Corporation 2019 Equity Incentive Plan. The remaining RSUs will convert on February 24, 2027 and February 24, 2028 Read SEC document |
| February 24, 2026 Filed Feb 26, 2026 21:09 UTC | ALLSTATE CORP ALL · Entity 2989 | Tax withholdingCommon Stock | 458 | $209.82 | $96,097.56 |
DisclosureSEC source: 0000899051-26-000045 · form4.xml · nonDerivative · entry 2 Dugenske John E · CIK 0001699842 · Chief Financial Officer · Pres, Invest. & Corp. Strategy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,050 Read SEC document |
| February 24, 2026 Filed Feb 26, 2026 21:09 UTC | ALLSTATE CORP ALL · Entity 2989 | Exercise / conversionCommon Stock | 1,033 | $0.00 | $0.00 |
DisclosureSEC source: 0000899051-26-000045 · form4.xml · nonDerivative · entry 1 Dugenske John E · CIK 0001699842 · Chief Financial Officer · Pres, Invest. & Corp. Strategy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,508 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Conversion of previously awarded Restricted Stock Units (RSUs) into an equal number of common shares, without the payment of any consideration, pursuant to The Allstate Corporation 2019 Equity Incentive Plan. The remaining RSUs will convert on February 24, 2027 and February 24, 2028 Read SEC document |
| February 21, 2026 Filed Feb 23, 2026 21:58 UTC | ALLSTATE CORP ALL · Entity 2989 | Exercise / conversionRestricted Stock Units · Derivative | 1,558 | $0.00 | $0.00 |
DisclosureSEC source: 0000899051-26-000035 · form4.xml · derivative · entry 6 Dugenske John E · CIK 0001699842 · Chief Financial Officer · Pres, Invest. & Corp. Strategy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,558 Underlying: Common Stock · 1,558 shares Expires 2027-02-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Conversion of previously awarded Restricted Stock Units (RSUs) into an equal number of common shares, without the payment of any consideration, pursuant to The Allstate Corporation 2019 Equity Incentive Plan. The remaining RSUs will convert on February 21, 2027. F1 · derivative.exercise_date: Conversion of previously awarded Restricted Stock Units (RSUs) into an equal number of common shares, without the payment of any consideration, pursuant to The Allstate Corporation 2019 Equity Incentive Plan. The remaining RSUs will convert on February 21, 2027. Read SEC document |
| February 21, 2026 Filed Feb 23, 2026 21:58 UTC | ALLSTATE CORP ALL · Entity 2989 | Tax withholdingCommon Stock | 691 | $206.37 | $142,601.67 |
DisclosureSEC source: 0000899051-26-000035 · form4.xml · nonDerivative · entry 2 Dugenske John E · CIK 0001699842 · Chief Financial Officer · Pres, Invest. & Corp. Strategy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,475 Read SEC document |
| February 21, 2026 Filed Feb 23, 2026 21:58 UTC | ALLSTATE CORP ALL · Entity 2989 | Exercise / conversionCommon Stock | 1,558 | $0.00 | $0.00 |
DisclosureSEC source: 0000899051-26-000035 · form4.xml · nonDerivative · entry 1 Dugenske John E · CIK 0001699842 · Chief Financial Officer · Pres, Invest. & Corp. Strategy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,166 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Conversion of previously awarded Restricted Stock Units (RSUs) into an equal number of common shares, without the payment of any consideration, pursuant to The Allstate Corporation 2019 Equity Incentive Plan. The remaining RSUs will convert on February 21, 2027. Read SEC document |
| February 19, 2026 Filed Feb 23, 2026 21:58 UTC | ALLSTATE CORP ALL · Entity 2989 | GrantRestricted Stock Units · Derivative | 2,975 | $0.00 | $0.00 |
DisclosureSEC source: 0000899051-26-000035 · form4.xml · derivative · entry 5 Dugenske John E · CIK 0001699842 · Chief Financial Officer · Pres, Invest. & Corp. Strategy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,975 Underlying: Common Stock · 2,975 shares Expires 2029-02-19 F3 · derivative.exercise_price: Award of Restricted Stock Units (RSUs) granted on February 19, 2026, under The Allstate Corporation 2019 Equity Incentive Plan. Each RSU represents the right to receive, without payment of any consideration, one share of Allstate common stock on the conversion date, with any fractional RSU to be rounded as provided for in award agreement. The RSUs will convert in three equal increments on February 19, 2027, February 19, 2028, and February 19, 2029. F3 · derivative.exercise_date: Award of Restricted Stock Units (RSUs) granted on February 19, 2026, under The Allstate Corporation 2019 Equity Incentive Plan. Each RSU represents the right to receive, without payment of any consideration, one share of Allstate common stock on the conversion date, with any fractional RSU to be rounded as provided for in award agreement. The RSUs will convert in three equal increments on February 19, 2027, February 19, 2028, and February 19, 2029. Read SEC document |
| February 19, 2026 Filed Feb 23, 2026 21:58 UTC | ALLSTATE CORP ALL · Entity 2989 | GrantEmployee Stock Option (Right to Buy) · Derivative | 12,191 | $0.00 Strike: $203.22 | $0.00 |
DisclosureSEC source: 0000899051-26-000035 · form4.xml · derivative · entry 4 Dugenske John E · CIK 0001699842 · Chief Financial Officer · Pres, Invest. & Corp. Strategy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,191 Underlying: Common Stock · 12,191 shares Expires 2036-02-19 F2 · derivative.exercise_date: Option exercisable in three increments, with one third vesting on February 19, 2027, February 19, 2028, and February 19, 2029, with any fractional shares to be rounded as provided for in award agreement. Read SEC document |
| February 13, 2026 Filed Feb 18, 2026 21:24 UTC | ALLSTATE CORP ALL · Entity 2989 | Tax withholdingCommon Stock | 7,976 | $207.51 | $1,655,099.76 |
DisclosureSEC source: 0000899051-26-000022 · form4.xml · nonDerivative · entry 2 Dugenske John E · CIK 0001699842 · Chief Financial Officer · Pres, Invest. & Corp. Strategy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,608 F2 · price: Shares withheld to satisfy tax withholding obligations incident to the conversion of performance stock award. Read SEC document |
| February 13, 2026 Filed Feb 18, 2026 21:24 UTC | ALLSTATE CORP ALL · Entity 2989 | GrantCommon Stock | 19,588 | $0.00 | $0.00 |
DisclosureSEC source: 0000899051-26-000022 · form4.xml · nonDerivative · entry 1 Dugenske John E · CIK 0001699842 · Chief Financial Officer · Pres, Invest. & Corp. Strategy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,584 F1 · price: Shares acquired upon conversion of 2023 performance stock award, pursuant to The Allstate Corporation 2019 Equity Incentive Plan. Read SEC document |
| October 03, 2025 Filed Oct 7, 2025 20:08 UTC | ALLSTATE CORP ALL · Entity 2989 | GrantRestricted Stock Units · Derivative | 4,743 | $0.00 | $0.00 |
DisclosureSEC source: 0000899051-25-000086 · form4.xml · derivative · entry 1 Dugenske John E · CIK 0001699842 · Chief Financial Officer · Pres, Invest. & Corp. Strategy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,743 Underlying: Common Stock · 4,743 shares Expires 2028-10-03 F1 · derivative.exercise_price: Award of Restricted Stock Units (RSUs) granted on October 3, 2025, under The Allstate Corporation 2019 Equity Incentive Plan. Each RSU represents the right to receive, without payment of any consideration, one share of Allstate common stock on the conversion date, with any fractional RSU to be rounded as provided for in award agreement. The RSUs will convert in three equal increments on October 3, 2026, October 3, 2027, and October 3, 2028. F1 · derivative.exercise_date: Award of Restricted Stock Units (RSUs) granted on October 3, 2025, under The Allstate Corporation 2019 Equity Incentive Plan. Each RSU represents the right to receive, without payment of any consideration, one share of Allstate common stock on the conversion date, with any fractional RSU to be rounded as provided for in award agreement. The RSUs will convert in three equal increments on October 3, 2026, October 3, 2027, and October 3, 2028. Read SEC document |
| February 24, 2025 Filed Feb 26, 2025 21:18 UTC | ALLSTATE CORP ALL · Entity 2989 | GrantEmployee Stock Option (Right to Buy) · Derivative | 12,055 | $0.00 Strike: $188.75 | $0.00 |
DisclosureSEC source: 0001127602-25-006851 · form4.xml · derivative · entry 2 Dugenske John E · CIK 0001699842 · Pres, Invest. & Corp. Strategy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,055 Underlying: Common Stock · 12,055 shares Expires 2035-02-24 F2 · derivative.exercise_date: Option exercisable in three increments, with one third vesting on February 24, 2026, February 24, 2027, and February 24, 2028, with any fractional shares to be rounded as provided for in award agreement. Read SEC document |
| February 24, 2025 Filed Feb 26, 2025 21:18 UTC | ALLSTATE CORP ALL · Entity 2989 | GrantRestricted Stock Units · Derivative | 3,099 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-006851 · form4.xml · derivative · entry 1 Dugenske John E · CIK 0001699842 · Pres, Invest. & Corp. Strategy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,099 Underlying: Common Stock · 3,099 shares Expires 2028-02-24 F1 · derivative.exercise_price: Award of Restricted Stock Units (RSUs) granted on February 24, 2025, under The Allstate Corporation 2019 Equity Incentive Plan. Each RSU represents the right to receive, without payment of any consideration, one share of Allstate common stock on the conversion date, with any fractional RSU to be rounded as provided for in award agreement. The RSUs will convert in three equal increments on February 24, 2026, February 24, 2027, and February 24, 2028. F1 · derivative.exercise_date: Award of Restricted Stock Units (RSUs) granted on February 24, 2025, under The Allstate Corporation 2019 Equity Incentive Plan. Each RSU represents the right to receive, without payment of any consideration, one share of Allstate common stock on the conversion date, with any fractional RSU to be rounded as provided for in award agreement. The RSUs will convert in three equal increments on February 24, 2026, February 24, 2027, and February 24, 2028. Read SEC document |
| February 21, 2025 Filed Feb 25, 2025 21:30 UTC | ALLSTATE CORP ALL · Entity 2989 | Exercise / conversionRestricted Stock Units · Derivative | 1,557 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-006620 · form4.xml · derivative · entry 4 Dugenske John E · CIK 0001699842 · Pres, Invest. & Corp. Strategy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,116 Underlying: Common Stock · 1,557 shares Expires 2027-02-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Conversion of previously awarded Restricted Stock Units (RSUs) into an equal number of common shares, without the payment of any consideration, pursuant to The Allstate Corporation 2019 Equity Incentive Plan. The remaining RSUs will convert on February 21, 2026 and February 21, 2027. F1 · derivative.exercise_date: Conversion of previously awarded Restricted Stock Units (RSUs) into an equal number of common shares, without the payment of any consideration, pursuant to The Allstate Corporation 2019 Equity Incentive Plan. The remaining RSUs will convert on February 21, 2026 and February 21, 2027. Read SEC document |
| February 21, 2025 Filed Feb 25, 2025 21:30 UTC | ALLSTATE CORP ALL · Entity 2989 | Tax withholdingCommon Stock | 690 | $185.66 | $128,105.40 |
DisclosureSEC source: 0001127602-25-006620 · form4.xml · nonDerivative · entry 2 Dugenske John E · CIK 0001699842 · Pres, Invest. & Corp. Strategy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,996 Read SEC document |
| February 21, 2025 Filed Feb 25, 2025 21:30 UTC | ALLSTATE CORP ALL · Entity 2989 | Exercise / conversionCommon Stock | 1,557 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-006620 · form4.xml · nonDerivative · entry 1 Dugenske John E · CIK 0001699842 · Pres, Invest. & Corp. Strategy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,686 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Conversion of previously awarded Restricted Stock Units (RSUs) into an equal number of common shares, without the payment of any consideration, pursuant to The Allstate Corporation 2019 Equity Incentive Plan. The remaining RSUs will convert on February 21, 2026 and February 21, 2027. Read SEC document |
| February 14, 2025 Filed Feb 19, 2025 22:08 UTC | ALLSTATE CORP ALL · Entity 2989 | Tax withholdingCommon Stock | 2,815 | $187.63 | $528,178.45 |
DisclosureSEC source: 0001127602-25-005566 · form4.xml · nonDerivative · entry 2 Dugenske John E · CIK 0001699842 · Pres, Invest. & Corp. Strategy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,129 F2 · shares: Shares withheld to satisfy tax withholding obligations incident to the conversion of performance stock award. Read SEC document |
| February 14, 2025 Filed Feb 19, 2025 22:08 UTC | ALLSTATE CORP ALL · Entity 2989 | GrantCommon Stock | 8,110 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-005566 · form4.xml · nonDerivative · entry 1 Dugenske John E · CIK 0001699842 · Pres, Invest. & Corp. Strategy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,944 F1 · shares: Shares acquired upon conversion of 2022 performance stock award, pursuant to The Allstate Corporation 2019 Equity Incentive Plan. Read SEC document |
| September 20, 2024 Filed Sep 24, 2024 20:31 UTC | ALLSTATE CORP ALL · Entity 2989 | GiftCommon Stock | 530 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-024374 · form4.xml · nonDerivative · entry 4 Dugenske John E · CIK 0001699842 · Pres, Invest. & Corp. Strategy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,834 Read SEC document |
| September 20, 2024 Filed Sep 24, 2024 20:31 UTC | ALLSTATE CORP ALL · Entity 2989 | SaleCommon Stock | 4,625 | $192.46 | $890,107.61 |
DisclosureSEC source: 0001127602-24-024374 · form4.xml · nonDerivative · entry 3 Dugenske John E · CIK 0001699842 · Pres, Invest. & Corp. Strategy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,364 F3 · price: Reflects weighted average sale price for open-market sales transactions reported herein. Actual sales prices ranged from $192.220 to $193.130. The reporting person provided to the issuer, and will provide to any security holder of The Allstate Corporation or member of the SEC staff, full information regarding the number of shares sold at each separate price upon request. Read SEC document |
| September 20, 2024 Filed Sep 24, 2024 20:31 UTC | ALLSTATE CORP ALL · Entity 2989 | SaleCommon Stock | 15,799 | $191.68 | $3,028,341.26 |
DisclosureSEC source: 0001127602-24-024374 · form4.xml · nonDerivative · entry 2 Dugenske John E · CIK 0001699842 · Pres, Invest. & Corp. Strategy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,989 F2 · price: Reflects weighted average sale price for open-market sales transactions reported herein. Actual sales prices ranged from $191.220 to $192.200. The reporting person provided to the issuer, and will provide to any security holder of The Allstate Corporation or member of the SEC staff, full information regarding the number of shares sold at each separate price upon request. Read SEC document |
| September 20, 2024 Filed Sep 24, 2024 20:31 UTC | ALLSTATE CORP ALL · Entity 2989 | SaleCommon Stock | 15,943 | $190.77 | $3,041,455.68 |
DisclosureSEC source: 0001127602-24-024374 · form4.xml · nonDerivative · entry 1 Dugenske John E · CIK 0001699842 · Pres, Invest. & Corp. Strategy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,788 F1 · price: Reflects weighted average sale price for open-market sales transactions reported herein. Actual sales prices ranged from $190.220 to $191.215. The reporting person provided to the issuer, and will provide to any security holder of The Allstate Corporation or member of the SEC staff, full information regarding the number of shares sold at each separate price upon request. Read SEC document |
| March 26, 2024 Filed Mar 28, 2024 20:03 UTC | ALLSTATE CORP ALL · Entity 2989 | SaleCommon Stock | 31,000 | $170.20 | $5,276,203.10 |
DisclosureSEC source: 0001127602-24-011373 · form4.xml · nonDerivative · entry 1 Dugenske John E · CIK 0001699842 · Pres, Invest. & Corp. Strategy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,731 F1 · price: Reflects weighted average sale price for open-market sales transaction reported herein. Actual sale prices ranged from $170.150 to $170.380. The reporting person provided the issuer, and will provide any security holder of The Allstate Corporation or member of the SEC staff, full information regarding the number of shares sold at each separate price upon request. Read SEC document |
| February 21, 2024 Filed Feb 23, 2024 21:19 UTC | ALLSTATE CORP ALL · Entity 2989 | GrantRestricted Stock Units · Derivative | 3,634 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-006612 · form4.xml · derivative · entry 2 Dugenske John E · CIK 0001699842 · Pres, Invest. & Corp. Strategy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,634 Underlying: Common Stock · 3,634 shares Expires 2027-02-21 F2 · derivative.exercise_price: Award of Restricted Stock Units (RSUs) granted on February 21, 2024, under The Allstate Corporation 2019 Equity Incentive Plan. Each RSU represents the right to receive, without payment of any consideration, one share of Allstate common stock on the conversion date, with any fractional RSU to be rounded as provided for in award agreement. The RSUs will convert in three equal increments on February 21, 2025, February 21, 2026, and February 21, 2027. F2 · derivative.exercise_date: Award of Restricted Stock Units (RSUs) granted on February 21, 2024, under The Allstate Corporation 2019 Equity Incentive Plan. Each RSU represents the right to receive, without payment of any consideration, one share of Allstate common stock on the conversion date, with any fractional RSU to be rounded as provided for in award agreement. The RSUs will convert in three equal increments on February 21, 2025, February 21, 2026, and February 21, 2027. Read SEC document |
| February 21, 2024 Filed Feb 23, 2024 21:19 UTC | ALLSTATE CORP ALL · Entity 2989 | GrantEmployee Stock Option (Right to Buy) · Derivative | 14,999 | $0.00 Strike: $159.17 | $0.00 |
DisclosureSEC source: 0001127602-24-006612 · form4.xml · derivative · entry 1 Dugenske John E · CIK 0001699842 · Pres, Invest. & Corp. Strategy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,999 Underlying: Common Stock · 14,999 shares Expires 2034-02-21 F1 · derivative.exercise_date: Option exercisable in three increments, with one third vesting on February 21, 2025, February 21, 2026, and February 21, 2027, with any fractional shares to be rounded as provided for in award agreement. Read SEC document |
| February 21, 2024 Filed Mar 8, 2024 21:16 UTC Amendment | ALLSTATE CORP ALL · Entity 2989 | GrantRestricted Stock Units · Derivative | 4,673 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-009187 · form4a.xml · derivative · entry 2 Dugenske John E · CIK 0001699842 · Pres, Invest. & Corp. Strategy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,673 Underlying: Common Stock · 4,673 shares Expires 2027-02-21 F3 · derivative.exercise_price: Award of Restricted Stock Units (RSUs) granted on February 21, 2024, under The Allstate Corporation 2019 Equity Incentive Plan. Each RSU represents the right to receive, without payment of any consideration, one share of Allstate common stock on the conversion date, with any fractional RSU to be rounded as provided for in award agreement. The RSUs will convert in three equal increments on February 21, 2025, February 21, 2026, and February 21, 2027. F1 · shares: The original Form 4, filed on February 23, 2024, is being amended by this Form 4 to correct a calculation error that misreported the number of Options and Restricted Stock Units (RSUs) granted to the reporting person on February 21, 2024. This amendment correctly reports the number of Options and RSUs granted to the reporting person on February 21, 2024. F3 · derivative.exercise_date: Award of Restricted Stock Units (RSUs) granted on February 21, 2024, under The Allstate Corporation 2019 Equity Incentive Plan. Each RSU represents the right to receive, without payment of any consideration, one share of Allstate common stock on the conversion date, with any fractional RSU to be rounded as provided for in award agreement. The RSUs will convert in three equal increments on February 21, 2025, February 21, 2026, and February 21, 2027. F1 · derivative.underlying_shares: The original Form 4, filed on February 23, 2024, is being amended by this Form 4 to correct a calculation error that misreported the number of Options and Restricted Stock Units (RSUs) granted to the reporting person on February 21, 2024. This amendment correctly reports the number of Options and RSUs granted to the reporting person on February 21, 2024. F1 · balance_after: The original Form 4, filed on February 23, 2024, is being amended by this Form 4 to correct a calculation error that misreported the number of Options and Restricted Stock Units (RSUs) granted to the reporting person on February 21, 2024. This amendment correctly reports the number of Options and RSUs granted to the reporting person on February 21, 2024. Read SEC document |
| February 21, 2024 Filed Mar 8, 2024 21:16 UTC Amendment | ALLSTATE CORP ALL · Entity 2989 | GrantEmployee Stock Option (Right to Buy) · Derivative | 18,810 | $0.00 Strike: $159.17 | $0.00 |
DisclosureSEC source: 0001127602-24-009187 · form4a.xml · derivative · entry 1 Dugenske John E · CIK 0001699842 · Pres, Invest. & Corp. Strategy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,810 Underlying: Common Stock · 18,810 shares Expires 2034-02-21 F1 · shares: The original Form 4, filed on February 23, 2024, is being amended by this Form 4 to correct a calculation error that misreported the number of Options and Restricted Stock Units (RSUs) granted to the reporting person on February 21, 2024. This amendment correctly reports the number of Options and RSUs granted to the reporting person on February 21, 2024. F2 · derivative.exercise_date: Option exercisable in three increments, with one third vesting on February 21, 2025, February 21, 2026, and February 21, 2027, with any fractional shares to be rounded as provided for in award agreement. F1 · derivative.underlying_shares: The original Form 4, filed on February 23, 2024, is being amended by this Form 4 to correct a calculation error that misreported the number of Options and Restricted Stock Units (RSUs) granted to the reporting person on February 21, 2024. This amendment correctly reports the number of Options and RSUs granted to the reporting person on February 21, 2024. F1 · balance_after: The original Form 4, filed on February 23, 2024, is being amended by this Form 4 to correct a calculation error that misreported the number of Options and Restricted Stock Units (RSUs) granted to the reporting person on February 21, 2024. This amendment correctly reports the number of Options and RSUs granted to the reporting person on February 21, 2024. Read SEC document |
| February 18, 2024 Filed Feb 21, 2024 21:14 UTC | ALLSTATE CORP ALL · Entity 2989 | Tax withholdingCommon Stock | 1,414 | $161.78 | $228,756.92 |
DisclosureSEC source: 0001127602-24-006049 · form4.xml · nonDerivative · entry 2 Dugenske John E · CIK 0001699842 · Pres, Invest. & Corp. Strategy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 94,731 F2 · shares: Shares withheld to satisfy tax withholding obligations incident to the conversion of performance stock award. Read SEC document |
| February 18, 2024 Filed Feb 21, 2024 21:14 UTC | ALLSTATE CORP ALL · Entity 2989 | GrantCommon Stock | 4,754 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-006049 · form4.xml · nonDerivative · entry 1 Dugenske John E · CIK 0001699842 · Pres, Invest. & Corp. Strategy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 96,145 F1 · shares: Shares acquired upon conversion of 2021 performance stock award, pursuant to The Allstate Corporation 2019 Equity Incentive Plan. Read SEC document |
| February 19, 2023 Filed Feb 21, 2023 21:59 UTC | ALLSTATE CORP ALL · Entity 2989 | Tax withholdingCommon Stock | 5,592 | $135.05 | $755,199.60 |
DisclosureSEC source: 0001127602-23-006229 · form4.xml · nonDerivative · entry 2 Dugenske John E · CIK 0001699842 · Pres, Invest. & Corp. Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,391 F2 · shares: Shares withheld to satisfy tax withholding obligations incident to the conversion of performance stock award. Read SEC document |
| February 19, 2023 Filed Feb 21, 2023 21:59 UTC | ALLSTATE CORP ALL · Entity 2989 | GrantCommon Stock | 15,081 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-006229 · form4.xml · nonDerivative · entry 1 Dugenske John E · CIK 0001699842 · Pres, Invest. & Corp. Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,983 F1 · shares: Shares acquired upon conversion of 2020 performance stock award, pursuant to The Allstate Corporation 2019 Equity Incentive Plan. Read SEC document |
| February 16, 2023 Filed Feb 21, 2023 21:59 UTC | ALLSTATE CORP ALL · Entity 2989 | GrantEmployee Stock Option (Right to Buy) · Derivative | 36,008 | $0.00 Strike: $137.10 | $0.00 |
DisclosureSEC source: 0001127602-23-006229 · form4.xml · derivative · entry 4 Dugenske John E · CIK 0001699842 · Pres, Invest. & Corp. Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,008 Underlying: Common Stock · 36,008 shares Expires 2033-02-16 F3 · derivative.exercise_date: Option exercisable in three increments, with one third vesting on February 16, 2024, February 16, 2025, and February 16, 2026, with any fractional shares to be rounded as provided for in award agreement. Read SEC document |
| February 17, 2022 Filed Feb 22, 2022 21:39 UTC | ALLSTATE CORP ALL · Entity 2989 | GrantEmployee Stock Option (Right to Buy) · Derivative | 50,810 | $0.00 Strike: $122.64 | $0.00 |
DisclosureSEC source: 0001127602-22-006051 · form4.xml · derivative · entry 1 Dugenske John E · CIK 0001699842 · Pres, Invest. & Fin. Prod. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,810 Underlying: Common Stock · 50,810 shares Expires 2032-02-17 F1 · derivative.exercise_date: Option exercisable in three increments, with one third vesting on February 17, 2023, February 17, 2024, and February 17, 2025, with any fractional shares to be rounded as provided for in award agreement. Read SEC document |
| February 07, 2022 Filed Feb 9, 2022 21:32 UTC | ALLSTATE CORP ALL · Entity 2989 | Tax withholdingCommon Stock | 11,753 | $124.76 | $1,466,304.28 |
DisclosureSEC source: 0001127602-22-003960 · form4.xml · nonDerivative · entry 2 Dugenske John E · CIK 0001699842 · Pres, Invest. & Fin. Prod. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,902 F2 · shares: Shares withheld to satisfy tax withholding obligations incident to the conversion of performance stock award. Read SEC document |
| February 07, 2022 Filed Feb 9, 2022 21:32 UTC | ALLSTATE CORP ALL · Entity 2989 | GrantCommon Stock | 29,202 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-003960 · form4.xml · nonDerivative · entry 1 Dugenske John E · CIK 0001699842 · Pres, Invest. & Fin. Prod. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,655 F1 · shares: Shares acquired upon conversion of 2019 performance stock award, pursuant to The Allstate Corporation 2013 Equity Incentive Plan. Read SEC document |
| May 10, 2021 Filed May 12, 2021 20:15 UTC | ALLSTATE CORP ALL · Entity 2989 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 57,540 | $0.00 Strike: $81.86 | $0.00 |
DisclosureSEC source: 0001127602-21-016381 · form4.xml · derivative · entry 10 Dugenske John E · CIK 0001699842 · Pres, Invest. & Fin. Prod. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 57,540 shares Expires 2027-03-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 10, 2021 Filed May 12, 2021 20:15 UTC | ALLSTATE CORP ALL · Entity 2989 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 40,160 | $0.00 Strike: $92.46 | $0.00 |
DisclosureSEC source: 0001127602-21-016381 · form4.xml · derivative · entry 9 Dugenske John E · CIK 0001699842 · Pres, Invest. & Fin. Prod. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,081 Underlying: Common Stock · 40,160 shares Expires 2029-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Stock option award granted on February 8, 2019, for 60,241 shares of common stock vesting in three equal increments. The remaining increment will vest on February 8, 2022. Read SEC document |
| May 10, 2021 Filed May 12, 2021 20:15 UTC | ALLSTATE CORP ALL · Entity 2989 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 53,991 | $0.00 Strike: $92.80 | $0.00 |
DisclosureSEC source: 0001127602-21-016381 · form4.xml · derivative · entry 8 Dugenske John E · CIK 0001699842 · Pres, Invest. & Fin. Prod. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 53,991 shares Expires 2028-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 10, 2021 Filed May 12, 2021 20:15 UTC | ALLSTATE CORP ALL · Entity 2989 | SaleCommon Stock | 57,543 | $135.74 | $7,810,886.82 |
DisclosureSEC source: 0001127602-21-016381 · form4.xml · nonDerivative · entry 6 Dugenske John E · CIK 0001699842 · Pres, Invest. & Fin. Prod. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,453 F3 · price: Reflects weighted average sale price for open-market sales transaction reported herein. Actual sales prices ranged from $135.36 to $136.16. The reporting person provided to the issuer, and will provide any security holder of The Allstate Corporation or member of the SEC staff, full information regarding the number of shares sold at each separate price upon request. Read SEC document |
| May 10, 2021 Filed May 12, 2021 20:15 UTC | ALLSTATE CORP ALL · Entity 2989 | SaleCommon Stock | 90,828 | $135.05 | $12,266,321.40 |
DisclosureSEC source: 0001127602-21-016381 · form4.xml · nonDerivative · entry 5 Dugenske John E · CIK 0001699842 · Pres, Invest. & Fin. Prod. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,996 F2 · price: Reflects weighted average sale price for open-market sales transaction reported herein. Actual sales prices ranged from $134.36 to $135.35. The reporting person provided to the issuer, and will provide any security holder of The Allstate Corporation or member of the SEC staff, full information regarding the number of shares sold at each separate price upon request. Read SEC document |
| May 10, 2021 Filed May 12, 2021 20:15 UTC | ALLSTATE CORP ALL · Entity 2989 | SaleCommon Stock | 3,320 | $133.66 | $443,751.20 |
DisclosureSEC source: 0001127602-21-016381 · form4.xml · nonDerivative · entry 4 Dugenske John E · CIK 0001699842 · Pres, Invest. & Fin. Prod. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 212,824 F1 · price: Reflects weighted average sale price for open-market sales transaction reported herein. Actual sales prices ranged from $133.26 to $134.14. The reporting person provided to the issuer, and will provide any security holder of The Allstate Corporation or member of the SEC staff, full information regarding the number of shares sold at each separate price upon request. Read SEC document |
| May 10, 2021 Filed May 12, 2021 20:15 UTC | ALLSTATE CORP ALL · Entity 2989 | Exercise / conversionCommon Stock | 57,540 | $81.86 | $4,710,224.40 |
DisclosureSEC source: 0001127602-21-016381 · form4.xml · nonDerivative · entry 3 Dugenske John E · CIK 0001699842 · Pres, Invest. & Fin. Prod. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 216,144 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 10, 2021 Filed May 12, 2021 20:15 UTC | ALLSTATE CORP ALL · Entity 2989 | Exercise / conversionCommon Stock | 40,160 | $92.46 | $3,713,193.60 |
DisclosureSEC source: 0001127602-21-016381 · form4.xml · nonDerivative · entry 2 Dugenske John E · CIK 0001699842 · Pres, Invest. & Fin. Prod. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 158,604 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 10, 2021 Filed May 12, 2021 20:15 UTC | ALLSTATE CORP ALL · Entity 2989 | Exercise / conversionCommon Stock | 53,991 | $92.80 | $5,010,364.80 |
DisclosureSEC source: 0001127602-21-016381 · form4.xml · nonDerivative · entry 1 Dugenske John E · CIK 0001699842 · Pres, Invest. & Fin. Prod. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,444 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.